SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Sandvig Axel)
 

Search: WFRF:(Sandvig Axel) > (2015-2019) > Analysis of Codman ...

Analysis of Codman microcerebrospinal fluid shunt

Sandvig, Axel (author)
Umeå universitet,Klinisk neurovetenskap,Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway
Arnell, Kai (author)
Malm, Jan (author)
Umeå universitet,Klinisk neurovetenskap
show more...
Eklund, Anders, 1965- (author)
Umeå universitet,Radiofysik
Koskinen, Lars-Owe D. (author)
Umeå universitet,Klinisk neurovetenskap
show less...
 (creator_code:org_t)
2018-09-11
2018
English.
In: Brain and Behavior. - : John Wiley & Sons. - 2162-3279 .- 2162-3279. ; 8:10
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Introduction: Ventriculo-peritoneal cerebrospinal fluid (CSF) shunt is the most common method of treating pediatric hydrocephalus. The Codman microadjustable valve (CMAV) is a CSF shunt constructed for children. The objective of the study was (a) to analyze complications after insertion of a CMAV shunt in hydrocephalic children, (b)to analyze complications after replacing a CMAV by an adult-type Codman Hakim adjustable valve shunt (CHAV), and to (c) analyze the in vitro characteristics of the CMAV shunt and correlate the findings with the clinical performance of the shunt.Methods: A retrospective study analyzed a cohort of hydrocephalic children who had received a CMAV shunt and later replaced by a CHAV shunt. We report on the complications that resulted from replacing the CMAV with the CHAV. We tested six CMAV shunts with or without an antisiphon device (ASD) in which opening pressure, resistance, sensitivity to abdominal pressure, ASD position dependency, and function were determined. The test results were correlated with the clinical performance of the shunt in the retrospective study.Results: Thirty-seven children (19 boys, 18 girls) were identified. Within the first month after shunt placement, a total of 10 patients (27%) developed complications including infections, hygromas, and shunt dysfunction. Shunt survival varied from 1week to 145 months. Over the 10-year follow-up period, 13 children had their shunts replaced, six of them with a CHAV without any further complications. A bench test of the CMAV was done to test whether the opening pressure was in agreement with the manufacturer's specifications. Our results were generally in agreement with specifications stated by the manufacturer.Conclusion: Replacing a CMAV with a CHAV was well tolerated by the patients. Bench test results were generally in agreement with manufacturers specifications. Replacing a CMAV with a CHAV in pediatric hydrocephalus patients can be accomplished safely.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Pediatrik (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Pediatrics (hsv//eng)

Keyword

cerebrospinal fluid
clinical retrospective study

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Sandvig, Axel
Arnell, Kai
Malm, Jan
Eklund, Anders, ...
Koskinen, Lars-O ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Pediatrics
Articles in the publication
Brain and Behavi ...
By the university
Umeå University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view